Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of ECSP044949ApublicationCriticalpatent/ECSP044949A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
La invención proporciona una formulación parenteral, liofilizada, amorfa de olanzapina.The invention provides a parenteral, lyophilized, amorphous formulation of olanzapine.
ECSP0449492001-07-202004-01-19
LIOPHILIZED FORMULATION OF 2-METHYL-TIENO-BENZODIAZEPINA
ECSP044949A
(en)